How we work: our editorial standards

When Sean or Ste make a factual claim, it's either sourced or cut. If they can't point to where something comes from, it doesn't go in.

We don't pair CBD with medical conditions anywhere on the site, and we don't promise you outcomes. We'll tell you what a strain smells like, how an oil is made, and what the FSA says about intake. We won't tell you it'll fix your back or settle your head, because nobody honestly can.

When Sean or Ste touch health or wellbeing, they read it against current Food Standards Agency guidance before it goes out. That includes the FSA's advice that adults consume no more than 10mg of CBD a day. It's precautionary guidance rather than a hard limit, and plenty of products are dosed above that per serving, so we point to it for context and tell you to check the label.

CBD is sold in the UK as a food supplement, not a medicine. We write it that way, every time.

Our products are lab-tested, and we don't sell isolates or oils with terpenes added back in after the fact. What's in the plant is what's in the bottle.

Every flower, hash and oil page lists three things: the dominant terpenes, the cannabinoid breakdown, and the genetics and origin. That's how we expect to be judged. Full lab reports are available on request if you want to go deeper.

Sean founded Originals and writes about flower, strains, sourcing and the growers we work with. Ste runs the customer-facing side and writes much of the site, from blog posts to product pages. Benzil writes our independent strain reviews. These are the named writers the standards on this page apply to: real people who handle the plant and put their name to what they write.

You'll also see posts bylined Originals CBD Editorial, covering guides, UK regulation and product education. Some of that is written by outside contributors, so we treat it as general information rather than checked advice. There's more on what that means below.

We use first-name bylines because that's honestly who we are, and every author has a page telling you what they write about. We're not going to dress anyone up as a doctor or a professor. We're people who know this plant well and write about it plainly.

Posts bylined Originals CBD Editorial are there to give you a useful overview of a topic, and some are written by outside contributors rather than our own named team. We don't put them through the same claim-by-claim check, so treat them as a starting point, not the last word.

The content published under the Originals CBD Editorial byline is intended for general information only and does not constitute legal, medical or health advice. Views expressed do not necessarily reflect the legal or regulatory position of Originals CBD. Always seek independent professional advice if you have questions about your own circumstances.

Our strain reviews are written independently, and every one carries a disclosure saying so. A reviewer might receive product to write about. The opinion you read is still theirs, and we publish it whether it flatters the product or not.

If a batch disappoints the person reviewing it, that's what the review will say.

We date our content and we keep it current. When the rules change, a product changes, or we simply get something wrong, we go back and update the piece rather than leave it sitting there stale.

Spotted a mistake? Tell us. We'd genuinely rather know.

No hype. No fear-selling. No medical claims. And no pretending the science is settled where it isn't, because a lot of it isn't yet, and saying otherwise would be the easy lie.

The plant's worth talking about honestly. That's the whole point of doing this properly.